Citadel Advisors’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.23M | Sell |
288,004
-23,476
| -8% | -$264K | ﹤0.01% | 2279 |
|
|
2025
Q1 | $1.42M | Buy |
311,480
+182,278
| +141% | +$833K | ﹤0.01% | 2904 |
|
|
2024
Q4 | $729K | Sell |
129,202
-615,853
| -83% | -$3.47M | ﹤0.01% | 3593 |
|
|
2024
Q3 | $3.61M | Buy |
745,055
+237,695
| +47% | +$1.15M | ﹤0.01% | 2024 |
|
|
2024
Q2 | $2.48M | Sell |
507,360
-669,725
| -57% | -$3.27M | ﹤0.01% | 2243 |
|
|
2024
Q1 | $15.6M | Buy |
1,177,085
+727,265
| +162% | +$9.66M | ﹤0.01% | 1020 |
|
|
2023
Q4 | $6.27M | Buy |
449,820
+212,617
| +90% | +$2.96M | ﹤0.01% | 1520 |
|
|
2023
Q3 | $3.15M | Sell |
237,203
-458,837
| -66% | -$6.08M | ﹤0.01% | 1988 |
|
|
2023
Q2 | $13.1M | Buy |
696,040
+271,178
| +64% | +$5.08M | ﹤0.01% | 1039 |
|
|
2023
Q1 | $6.13M | Buy |
424,862
+388,028
| +1,053% | +$5.6M | ﹤0.01% | 1656 |
|
|
2022
Q4 | $713K | Sell |
36,834
-33,996
| -48% | -$658K | ﹤0.01% | 3525 |
|
|
2022
Q3 | $2.43M | Sell |
70,830
-1,010,725
| -93% | -$34.7M | ﹤0.01% | 2546 |
|
|
2022
Q2 | $16.5M | Buy |
1,081,555
+101,225
| +10% | +$1.55M | ﹤0.01% | 948 |
|
|
2022
Q1 | $22.4M | Buy |
980,330
+433,120
| +79% | +$9.88M | ﹤0.01% | 842 |
|
|
2021
Q4 | $20.2M | Sell |
547,210
-119,174
| -18% | -$4.39M | ﹤0.01% | 923 |
|
|
2021
Q3 | $30.5M | Sell |
666,384
-163,205
| -20% | -$7.47M | 0.01% | 666 |
|
|
2021
Q2 | $48.7M | Buy |
+829,589
| New | +$48.7M | 0.01% | 507 |
|